Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 11:31 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 625–648 of 121,474 matching trials from the live ClinicalTrials.gov search.

Filters: Completed Clear all

Conditions: Lymphoma
Interventions: Zolinza (vorinostat), Cyclophosphamide, Doxorubicin, Vincristine, Prednisone; Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
Interventions: paclitaxel, bavituximab, laboratory biomarker analysis, pharmacological study; Drug · Biological · Other
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Alcohol Dependence, Bipolar Disorder
Interventions: Acamprosate, Placebo; Drug
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 65 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Lower Eyelid Steatoblepharon (Excess Eyelid Fat)
Interventions: XOPH5 Ointment, Placebo; Drug
Lead sponsor: Topokine Therapeutics, Inc.; Industry
Eligibility: 40 Years to 70 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Renal Failure, Renal Artery Stenosis
Interventions: 62Cu-ethylglyoxal bis(thiosemicarbazone), 15O-water, Positron Emission Tomography; Drug · Procedure
Lead sponsor: Jeffrey L. Lacy; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: COVID, Covid-19, Corona Virus Infection, Coronavirus Infection, Coronavirus-19, SARS-CoV2, SARS-CoV Infection
Interventions: Ivermectin, Doxycycline Hcl, Zinc, Vitamin D3, Vitamin C; Drug · Dietary Supplement
Lead sponsor: ProgenaBiome; Other
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Ventura, California

Conditions: Multiple Myeloma, Non-Hodgkin's Lymphoma
Interventions: Enterade, Placebo, Standard Supportive Care; Dietary Supplement · Other
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 114 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Lewy Body Dementia, Parkinson Disease
Interventions: Sitagliptin, Dapagliflozin, Placebo; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 45 Years to 65 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Blood Pressure, Vascular Function, Adherence, Treatment
Interventions: App-Based Inspiratory Muscle Strength Training, Clinic-Based Inspiratory Muscle Strength Training; Device
Lead sponsor: University of Colorado, Boulder; Other
Eligibility: 18 Years and older
Enrollment: 33 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Boulder, Colorado

Conditions: Diabetes, Diabetes Mellitus, Type 2, Delivery Systems
Interventions: pump, insulin aspart; Device · Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 30 Years to 70 Years
Enrollment: 71 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 6
States / cities: Chula Vista, California • Miami, Florida • Witchita, Kansas + 3 more

Conditions: Malignancy, Immune System Diseases, Autoimmune Diseases
Interventions: Biospecimen Collection, Medical Chart Review, Questionnaires/Surveys; Procedure · Other
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Diagnostic Self Evaluation, Central Nervous System Diseases
Interventions: Dotarem (gadoterate meglumine), Magnevist (gadopentetate dimeglumine); Drug
Lead sponsor: Guerbet; Industry
Eligibility: 2 Years and older
Enrollment: 416 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 20
States / cities: Birmingham, Alabama • Tucson, Arizona • Indian Wells, California + 14 more

Conditions: Peripheral T-cell Lymphoma
Interventions: Belinostat; Drug
Lead sponsor: Spectrum Pharmaceuticals, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 129 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 42
States / cities: Duarte, California • La Verne, California • Palm Springs, California + 33 more

Conditions: Healthy
Interventions: Not listed
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 18 Years to 80 Years
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2007
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Basal Cell Carcinoma, Squamous Cell Carcinoma
Interventions: Blood Draw; Procedure
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Nasolabial Folds
Interventions: Perlane and Perlane-L; Device
Lead sponsor: Medicis Global Service Corporation; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009
U.S. locations: 3
States / cities: Coral Gables, Florida • Hunt Valley, Maryland • Mount Cisco, New York

Conditions: Prodromal Schizophrenia, Psychosis, Psychological Disorder, Psychological Stress
Interventions: Health Behaviors Group; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 13 Years to 17 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Aging
Interventions: Not listed
Lead sponsor: University of Nebraska; Other
Eligibility: 60 Years to 105 Years
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Diabetic Retinopathy, Diabetic Macular Edema
Interventions: Home vision monitoring using myVisionTrack®; Device
Lead sponsor: Vital Art and Science Incorporated; Industry
Eligibility: 40 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 2
States / cities: Dallas, Texas

Conditions: Smoking
Interventions: Patient feedback form; Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Anorexia Nervosa
Interventions: RhIGF-1 with transdermal 17-beta estradiol, Placebo and transdermal 17-beta estradiol; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 14 Years to 22 Years · Female only
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Fluid Balance, Input and Output, Inflammatory Mediators, Acute Kidney Injury, Mortality
Interventions: Not listed
Lead sponsor: University of Florida; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Breast Cancer
Interventions: Taxotere; Drug
Lead sponsor: Baylor Breast Care Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2004
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Tinnitus
Interventions: Tele-PTM, Wait List Control; Procedure
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 205 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Portland, Oregon

Search by objective public record fields.

SAHA + CHOP in Untreated T-cell Non-Hodgkin's Lymphoma

Paclitaxel and Bavituximab in Treating Patients With HER2-Negative Metastatic Breast Cancer

Acamprosate vs. Placebo in Bipolar Alcoholics

Phase 2 Study of XAF5 (XOPH5) Ointment for Reduction of Excess Eyelid Fat (Steatoblepharon)

Renal Blood Flow Measurement With Positron Emission Tomography (PET)

Trial of Combination Therapy to Treat COVID-19 Infection

A Study Evaluating a Proprietary Amino Acid Mixture (Enterade®) in Patients Receiving High-Dose Melphalan Conditioning Followed by Autologous Stem Cell Transplantation for Multiple Myeloma and Non-Hodgkin Lymphoma

Anti-Diabetic Medications to Fight PD and LBD

Smartphone App-guided Inspiratory Muscle Strength Training for Lowering Systolic Blood Pressure

A Study of the Treatment of Type 2 Diabetes With an Insulin Infusion Pump

Immuno-Oncology Database and Bioregistry

Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions

Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma

Learning a Motor Task Through Observation

Serum Concentration of Lidocaine After Local Injection During Mohs Micrographic Surgery

Safety Study That Compares Perlane to Perlane With Lidocaine (Perlane-L) While Correcting Wrinkles in the Area Around Your Nose

Feasibility Trial of a Lifestyle Intervention for CHR-P

Relationship Between Physical Activity and Stem Cells in Older Adults

Diabetic Retinopathy And the Myvisiontrack® (DRAMA) Study

Functional Assessment Screening Tablets - Patient Reported Measures

Effects of Anorexia Nervosa on Peak Bone Mass

Fluid Balance and Clinical Outcomes

Neoadjuvant Taxotere

Telephone Tinnitus Education for Patients With Traumatic Brain Injury (TBI)